Lipoprotein(a): A Genetically Determined, Causal, and Prevalent

The structure of Lipoprotein(a). The Lp(a) particle contains a single

Cover Story Emerging From the Shadows: Lp(a) - American College of Cardiology

Cover Story Emerging From the Shadows: Lp(a) - American College of Cardiology

Lipoprotein(a) the Insurgent: A New Insight into the Structure, Function, Metabolism, Pathogenicity, and Medications Affecting Lipoprotein(a) Molecule

Lipoprotein(a) Testing Trends in a Large Academic Health System in the United States

Is Lipoprotein(a) Clinically Actionable with Today's Evidence? The Answer is Yes

Lipoprotein(a) and risk of cognitive impairment in Black and White Americans: the Reasons for Geographic and Racial Differences in Stroke cohort - Research and Practice in Thrombosis and Haemostasis

Pharmaceuticals, Free Full-Text

LPA disruption with AAV-CRISPR potently lowers plasma apo(a) in transgenic mouse model: A proof-of-concept study: Molecular Therapy - Methods & Clinical Development

Genome-Wide Association Study Highlights APOH as a Novel Locus for Lipoprotein(a) Levels—Brief Report

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease